Universal vaccination against hepatitis A;Vacunación universal frente a la hepatitis A

Vacunas

Volumn 10, Issue 1, 2009, Pages 1-3

  Salleras, L ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS A VACCINE; HEPATITIS B VACCINE;

COST EFFECTIVENESS ANALYSIS; EDITORIAL; HEPATITIS A; HEPATITIS B; INCIDENCE; INFECTION CONTROL; VACCINATION;

EID: 67649411966     PISSN: 15769887     EISSN: 15788857     Source Type: Journal    
DOI: 10.1016/S1576-9887(09)71383-4     Document Type: Editorial

References (39)

1. Gocke D.J. Hepatitis A revisited. Ann Intern Med 105 (1986) 960-961
2. Fishman L.N., Jonas M.M., and Lavine J.E. Update on viral hepatitis in children. Pediatr Clin North Am 43 (1996) 57-74
3. Lemon S.M. Type A viral hepatitis: epidemiology, diagnosis, and prevention. Clin Chem 43 (1997) 1494-1499
4. Lemon S.M. Inactivated hepatitis A vaccines. JAMA 271 (1994) 1363-1364
5. Nothdurft H.D. Hepatitis A vaccines. Expert Rev Vaccines 7 (2008) 535-545
6. Van Herck K., and Van Damme P. Prevention of hepatitis A by Havrix: a review. Expert Rev Vaccines 4 (2005) 459-471
7. Bovier P.A. Epaxal: a virosomal vaccine for prevent hepatitis A infection. Expert Rev Vaccines 7 (2008) 1141-1150
8. Bovier P.A. Recent advances with a virosomal hepatitis A vaccine. Expert Opin Biol Ther 8 (2008) 1177-1185
9. Hammitt L.L., Bulkow L., Hennessy T.W., et al. Persistence of antibody to hepatitis A virus 10 years after vaccination among children and adults. J Infect Dis 198 (2008) 1776-1782
10. a ed. (2003), Masson, Barcelona 755-762
11. Salleras L., Bruguera M., Buti M., et al. Hepatitis A vaccination policy in Catalonia (Spain). Vacunas 1 (2000) 48-57
12. Lemon S.M., and Thomas D.L. Vaccine to prevent viral hepatitis. N Engl J Med 336 (1997) 196-204
13. Andre F.E. Universal mass vaccination against hepatitis A. Curr Top Microbiol Immunol 304 (2006) 95-114
14. CDC. Prevention of hepatitis A through active or passive immunization. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 45 (1996) 1-30
15. a ed. (2003), Masson, Barcelona 305-310
16. Hinman A. Eradication of vaccine preventable diseases. Ann Rev Public Health 20 (1999) 211-229
17. Domínguez A., Vidal J., Bruguera M., and Salleras L. Epidemiología de las hepatitis virales. Enf Infecc Microbiol Clin 105 (1995) 168-171
18. Salleras L., Bruguera M., Buti M., and Domínguez A. Prospects for vaccination against hepatitis A and B in Catalonia (Spain). Vaccine 18 Suppl. 1 (2000) S80-S82
19. Salleras L., Bruguera M., Vidal J., et al. Cambio en el patrón epidemiológico de la hepatitis A en Cataluña (España). Med Clin (Barc) 99 (1992) 87-89
20. Bruguera M., Salleras L., Plans P., et al. Cambios en la seroepidemiología de la infección por el virus de la hepatitis A en Cataluña en el período 1989-1996. Implicaciones para una nueva estrategia vacunal. Med Clin (Barc) 112 (1999) 406-408
21. Bruguera M., Bayas J.M., Vilella A., et al. Immunogenicity and reactogenicity of a combined hepatitis A and B vaccine in young adults. Vaccine 14 (1996) 1407-1411
22. Salleras L., Plans P., Vidal J., Domínguez A., Navas E., and Urbiztondo L. Serological evaluation of the universal hepatitis B vaccination programme of preadolescents in Catalonia (Spain). Vacunas 1 (2000) 3-6
23. Domínguez A., Salleras L., Carmona G., and Batalla J. Effectiveness of a mass hepatitis A vaccination program in preadolescents. Vaccine 21 (2003) 698-701
24. Domínguez A., Oviedo M., Carmona G., et al. Epidemiology of hepatitis A before and after the introduction of a universal vaccination programme in Catalonia, Spain. J Viral Hepat 15 Suppl. 2 (2008) 51-56
25. Rodríguez C., Basile L., Urbiztondo L., Borràs E., and Batalla J. Vacunación antihepatitis A: ¿selectiva o universal?. Vacunas 10 (2009) 4-8
26. Van Damme P., and Van Herck K. Effect of hepatitis A vaccination programs. JAMA 294 (2005) 194-201
27. Samandari T., Bell B.P., and Armstrong G.L. Quantifying the impact of hepatitis A immunization in the United States, 1995-2001. Vaccine 22 (2004) 4342-4350
28. Wasley A., Samandari T., and Bell B.P. Incidence of hepatitis A in the United States in the era of vaccination. JAMA 294 (2005) 194-201
29. Vogt T.M., Wise M.E., Bell B.P., and Finelli L. Declining hepatitis A mortality in the United States during the era of hepatitis A vaccination. J Infect Dis 197 (2008) 1282-1288
30. Dienstag J.L. Hepatitis A: the vaccine dividend. J Infect Dis 197 (2008) 1220-1222
31. CDC. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 55 (2006) 1-23
32. Lieberman J.M., Word B.M., Jacobs R.J., Dagan R., and Marchant C.D. Universal hepatitis A vaccination in the United States: a call for action. Ped Infect Dis. J 27 (2008) 287-291
33. Dagan R., Leventhal A., Anis E., Slater P., Ashur Y., and Shouval D. Incidence of hepatitis A in Israel following universal immunization of toddlers. JAMA 294 (2005) 202-210
34. Chodick G., Heymann A.D., Ashkenazi S., Kokia E., and Shalev V. Long-term trends in hepatitis A incidence following the inclusion of Hepatitis A vaccine in the routine nationwide immunization program. J Viral Hepat 15 Supl. 2 (2008) 62-65
35. MacIntyre C.R., Burgess M.A., Hull B., and McIntyre P.B. Hepatitis A vaccination options for Australia. J Paediatr Child Health 39 (2003) 83-87
36. Lopalco P.L., Prato R., Chironna M., Germinario C., and Quarto M. Control of hepatitis aby universal vaccination of adolescents, puglia, Italy. Emerg Infect Dis 14 (2008) 526-528
37. Salleras L., and Domínguez A. Vacuna frente a la hepatitis A en la adolescencia y la edad adulta joven. Vacunas 7 Supl. 1 (2006) 37-43
38. Navas E., Salleras L., Gisbert R., et al. Efficiency of the incorporation of the hepatitis A vaccine as a combined A+B vaccine to the hepatitis B vaccination programme of preadolescents in schools. Vaccine 23 (2005) 2185-2189
39. Belmaker I., Dukhan L., Yosef Y., Leventhal A., and Dagan R. Elimination of hepatitis ainfection outbreaks in day care and school settings in southern Israel after introduction of the national universal toddler hepatitis A immunization program. Pediatr Infect Dis J 26 (2007) 36-40